These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17517839)

  • 61. Overproduction of a metallo-beta-lactamase by a strong promoter causes high-level imipenem resistance in a clinical isolate of Pseudomonas aeruginosa.
    Takeda S; Nakai T; Ikeda F; Hatano K
    Chemotherapy; 2008; 54(3):181-7. PubMed ID: 18560224
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A carbapenem-susceptible Pseudomonas aeruginosa strain carrying the bla(SPM) gene.
    Pellegrino FL; Casali N; Nouér SA; Riley LW; Moreira BM
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):214-6. PubMed ID: 18308497
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
    Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
    Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Contributions of efflux pumps to high level resistance of Pseudomonas aeruginosa to ciprofloxacin.
    Wang DD; Sun TY; Hu YJ
    Chin Med J (Engl); 2007 Jan; 120(1):68-70. PubMed ID: 17254491
    [No Abstract]   [Full Text] [Related]  

  • 65. Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility.
    Breidenstein EB; Khaira BK; Wiegand I; Overhage J; Hancock RE
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4486-91. PubMed ID: 18824609
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
    Zhang Y; Bao Q; Gagnon LA; Huletsky A; Oliver A; Jin S; Langaee T
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4772-9. PubMed ID: 20713660
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor.
    Fraud S; Campigotto AJ; Chen Z; Poole K
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4478-82. PubMed ID: 18838593
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y; Yu XH; Wang R; An MM; Liang BB
    J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Release of DNA from Pseudomonas aeruginosa in vitro during spontaneous growth and treatment with ciprofloxacin].
    Peng DZ; Guymon CH; McManus AT; Xiao GX
    Zhonghua Wai Ke Za Zhi; 2005 Feb; 43(3):178-81. PubMed ID: 15842899
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria].
    Aggoune-Khinache N; Bensersa D; Henniche FZ; Daoudi M; Abdouni MA; Chabani A; Tiouit D; Naim M
    Med Mal Infect; 2009 Jun; 39(6):413-4. PubMed ID: 19111417
    [No Abstract]   [Full Text] [Related]  

  • 72. Structural requirements for the stability of novel cephalosporins to AmpC beta-lactamase based on 3D-structure.
    Murano K; Yamanaka T; Toda A; Ohki H; Okuda S; Kawabata K; Hatano K; Takeda S; Akamatsu H; Itoh K; Misumi K; Inoue S; Takagi T
    Bioorg Med Chem; 2008 Mar; 16(5):2261-75. PubMed ID: 18082409
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria.
    Drissi M; Ahmed ZB; Dehecq B; Bakour R; Plésiat P; Hocquet D
    Med Mal Infect; 2008 Apr; 38(4):187-91. PubMed ID: 18395380
    [TBL] [Abstract][Full Text] [Related]  

  • 74. IMP-4-producing Pseudomonas aeruginosa in a French patient repatriated from Malaysia: impact of early detection and control measures.
    Bert F; Vanjak D; Leflon-Guibout V; Mrejen S; Delpierre S; Redondo A; Nicolas-Chanoine MH
    Clin Infect Dis; 2007 Mar; 44(5):764-5. PubMed ID: 17278079
    [No Abstract]   [Full Text] [Related]  

  • 75. Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa.
    Chuanchuen R; Wannaprasat W; Schweizer HP
    Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):115-22. PubMed ID: 18567450
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
    Brazas MD; Breidenstein EB; Overhage J; Hancock RE
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4276-83. PubMed ID: 17893152
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Investigation of the Pseudomonas aeruginosa ampR gene and its role at the chromosomal ampC beta-lactamase promoter.
    Lodge J; Busby S; Piddock L
    FEMS Microbiol Lett; 1993 Aug; 111(2-3):315-20. PubMed ID: 8405939
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
    Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
    J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
    [TBL] [Abstract][Full Text] [Related]  

  • 79. YgfB increases β-lactam resistance in Pseudomonas aeruginosa by counteracting AlpA-mediated ampDh3 expression.
    Eggers O; Renschler FA; Michalek LA; Wackler N; Walter E; Smollich F; Klein K; Sonnabend MS; Egle V; Angelov A; Engesser C; Borisova M; Mayer C; Schütz M; Bohn E
    Commun Biol; 2023 Mar; 6(1):254. PubMed ID: 36894667
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital.
    Mammeri H; Eb F; Berkani A; Nordmann P
    J Antimicrob Chemother; 2008 Mar; 61(3):498-503. PubMed ID: 18250231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.